Competitive Disadvantages
Where do rivals beat it, and what does each gap cost?
Aptocrom's competitors beat it on scale: 지오영 holds the place of the industry's largest distributor with revenue of 3조4848억7500만원 in the last fiscal year, while Aptocrom's revenue was $7M in that period.
지오영, 백제약품 and 동원약품 have built nationwide logistics networks and trade with pharmacies and medical institutions throughout the country, and they lead in supply stability and efficiency. Aptocrom started its pharmaceutical distribution business in 2017 and carries more than 100 prescription drug items.
Competitive Landscape
Who does it compete with for the same buyer, and how do they differ?
Aptocrom competes at a fraction of the scale of the Korean pharmaceutical wholesale leaders, with $7M of revenue in its last fiscal year compared with 3조4848억원 for market leader 지오영, a figure the company recorded last year as an 8.7% increase, the highest among Korean pharmaceutical distributors.
지오영, 백제약품 and 동원약품 have built nationwide logistics networks and trade with pharmacies and medical institutions across the country, holding a leading position in supply stability and efficiency. 쥴릭파마코리아's revenue rose 33.32% to 1조1856억9000만원 from 8893억3200만원 the previous year.
Market Outlook
Is its category moving in its favor or against it?
Korean drug distribution is consolidating against Aptocrom: the top ten wholesalers raised their share of the roughly 36조원 market to 42.8% last year, up from 39.8% in 2022, 40.8% in 2023 and 41.7% in 2024, so the share left to distributors outside that group, including Aptocrom with $7M of revenue in its last fiscal year, is falling.
Concentration of the distribution structure raises the market entry barrier for small and medium distributors and can reduce the diversity of the distribution ecosystem. The number of Korean drug distributors with annual revenue above 1조원 rose from 5 in 2024 to 7 in 2025.
Product Overview
What does the product do for its buyer, and how is it delivered?
Aptocrom's core business is distributing prescription medicines: since beginning that business in 2017, it has distributed more than 100 prescription drug items, including antibiotics and digestive drugs, and lists its catalogue by therapeutic class, while also running an equipment-leasing business.
Aptocrom's prescription medicines include 큐라무스정, an antibiotic. The leasing business rents out the real estate, machinery, and equipment that the company owns.